Antibiotic SB22484 is a novel memberof the aurodox type antibiotic group produced in submerged-fermentation cultures of Streptomyces sp. NRRL1 5496.
In vitro, SB22484 antibiotics strongly inhibited neisseriae and were also active against Streptococci, Ureaplasma urealyticum and Haemophilus influenzae.
The novel aurodox type antibiotic SB22484 was isolated in the course of a discovery program for antibiotics having activity against neisseriae. During this search we found that aurodox type antibiotics were present in broths active against Neisseria caviae but inactive against Staphylococcus aureus. In fact aurodox type antibiotics characteristically show activity against anaerobes, neisseriae and Streptococci while are lacking activity against S. aureus1~4). These antibiotics inhibit bacterial protein synthesis by binding to elongation factor Tu (EF-Tu) 5'6) . This paper deals with the taxonomy of the producing strain and the isolation and characterization ofSB22484.
Materials and Methods Morphological and Cultural Characteristics of the Strain
The producing strain was isolated from a soil sample collected in a wheat field in the Valtellina valley inItaly.
Identification keys were used according to the classification ofPridham et al?) and color determination according to Maerz and Paul8) .
The cultural characteristics of the strain on various standard media and its ability to utilize different carbon sources were determined according to Shirling and Gottlieb9*, and Waksman10). Whole-cell analysis was carried out according to Staneck11*. The strain was deposited in the Northern Research Center of Agricultural Research Service with the accession No. NRRL15496.
Fermentation
A lyophilized culture of strain NRRL15496 was transferred onto a slant of oatmeal agar. After 10 days of incubation at 28°C, the slant was used to inoculate two baffled 2,000-ml Erlenmeyer flasks containing 500ml of seed medium (beef extract 0.5%, peptone 0.5%, enzymatically hydrolyzed casein 0.3%, yeast extract 0.5%, NaCl 0.15%, and glucose 2% in distilled water). The flasks were incubated for f Present address: Farmitalia Carlo Erba Research Labs., Via C. Imbonati 24, 20159 Milano, Italy.
40 hours at 28°C on a rotatory shaker at 220rpm. The culture was then transferred to a 50-liter fermenter containing 30liters of production medium (beef extract 0.4%, peptone 0.4%, NaCl 0.25%, yeast extract 0.1%, soybean meal 1%, glucose 2.5%, and CaCO30.5% in tap water). The culture was fermented for 24 hours at 28°C with 500rpm stirring and 1 v/v/minute aeration and then transferred into a 300-liter fermenter containing 200 liters of production medium. Fermentation was carried out at 28°C with 240 rpm stirring and 1 v/v/minute aeration flow. The antibiotic level was determined by paper-disk diffusion assay with N. caviae ATCC14659 in brain heart infusion agar at 37°C.
HPLC of SB22484 Complex
HPLC analysis was performed on a Bakerbond (5/mi) C8 (4.6x250mm) column eluted at 1.8 ml/minute flow rate with mixtures of two mobile phases, phase A: CH3CN-THF-40mM HCOONH4 (40:40:20), phase B: CH3CN-THF-40mM HCOONH4(10: 10: 80). These mobile phases were used for both analytical and preparative HPLCseparations. For analytical purposes a 20-minute linear gradient from 1 :9, phases A-B to 9: 1, phases A-B was used. Sample solutions of SB22484, in CH3CN-0.1m Na2CO3 (50 : 50), were injected and elution was followed by UVdetection at 320nm.
Isolation of Antibiotic SB22484 and Purification of the Individual Components The filtrate (170 liters) of the harvested broth was adjusted to pH 7.0 and extracted with ethyl acetate. The crude antibiotic (9.2 g) was precipitated from the concentrated organic phase upon addition of petroleum ether. This preparation (4.5 g) was purified on a chromatographic column containing 1.5 liters of Sephadex LH-20 equilibrated and eluted with methanol. The pooled fractions containing the antibiotic were concentrated to an oily residue which was dissolved in THF. The pure antibiotic complex (960mg) was precipitated upon addition of ethyl ether. The four individual factors which constitute the SB22484complex were isolated by preparative HPLCusing a Shimadzu LC-8Apreparative chromatograph. The complex (20mg) was dissolved in 1 ml of phase A (see above) and 1 ml of 1% (w/v) sodium bicarbonate, and the separation was performed on a Nucleosil 5 /xm C18 silica gel (20 x 250mm) column eluted at 20ml/minute flow rate with a 20 minute linear gradient from 1 :9, phases A-B to 5 : 5, phases A-B with UVdetection at 320 nm. Fractions from repeated chromatographic runs containing the same separated factor were pooled, the organic solvents were removedunder vacuum, and the residual aqueoussolutions wereextracted twice with ethyl acetate. The SB22484 factors wereprecipitated from the concentrated organic phase upon addition of ethyl ether.
Physico-chemical Analysis
The UV spectra of pH 7.0 phosphate buffer solutions of the antibiotics were recorded with a Perkin-Elmer model 320 spectrophotometer.
Liquid chromatography (LC)-MS was performed using an HP 5985 instrument working in negative ion mode, and connected with a Brownlee Labs RP18 (10/mi) HPLC column (4.6 x 250mm). The column was eluted at 1 ml/minute flow rate with a mixture of CH3CN-0.1 m HCOONH4 (6:4).
MICDetermination
For most strains MICwere determined by microbroth dilution methodology. MICfor Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae were determined by agar dilution; MIC for Clostridium perfringens, Mycoplasma gallisepticum, Ureaplasma urealyticum, Mycobacterium tuberculosis, Trichophyton mentagrophytes, and Trichomonas vaginalis by macrobroth dilution. Inocula were approximately 104 cfu/ml, unless otherwise indicated. M. gallisepticum inocula were 100-fold dilutions of 48 hours cultures; U. urealyticum inocula were 104 color changing u/ml; M. tuberculosis inocula were from 7-day broth cultures, T. mentagrophytes from 7-day slants and T. vaginalis from 48 hours broth cultures. Incubation times were 18~24 hours except for N. gonorrhoeae, N. meningitidis, H. influenzae, T. mentagrophytes, M. gallisepticum, T. vaginalis (48 hours) and M. tuberculosis (7 days). All bacteria were incubated at 37°C; Candida albicans and T. mentagrophytes at 30°C. N. gonorrhoeae and N. meningitidis were incubated in a 5%CO2atmosphere, C. perfringens in an anaerobic gas mixture. Bactericidal Activity Time kill experiments with N. gonorrhoeae L997 were performed in Difco GC base broth+ 1% IsoVitaleX using an inoculum of 107 cfu/ml. SB22484 (five and ten times the MIC) and spectinomycin (five times the MIC) were added to stationary or growing cells of N. gonorrhoeae. At intervals during incubation at 37°C in a 5% CO2 atmosphere, triplicate samples were removed and plated on Difco GC agar base+ 1% IsoVitaleX+ lOmg/liter hemin for viable counts. The plates were incubated for 48 hours at 37°C in a 5% CO2atmosphere.
Experimental Infections
Each control and treatment group contained five CD-I mice (Charles River) weighing 18~22 g. They were infected intraperitoneally with 0.5 ml of a bacterial suspension prepared by diluting overnight cultures of S. pyogenes or S. pneumoniaein sterile peptonized saline. Inocula were adjusted so that untreated animals died of septicemia within 48 hours. Animals were treated subcutaneously once daily for 3 days starting immediately after infection (S. pyogenes) or twice at 0 and 6 hours after infection (S. pneumoniae). On the 10th day, the ED50in mg/kg/treatment was calculated by the Spearmanand Kaerber method of literature12) from the percentage of surviving animals at each dose.
Serum Levels in the Mouse
For each sampling time, five male and five female mice were treated subcutaneously with lOO mg/kg of SB22484. 0.5 ml of blood/animal were collected by cardiac puncture, and the pooled blood was allowed to clot. SB22484was assayed microbiologically on E. coli G1625, a hyperpermeable strain of E. coli K-12, which is sensitive to aurodox type antibiotics (G. Carniti and P. B. Goldstein, unpublished results).
Results

Morphological and Cultural Characteristics
of Strain NRRL15496 The strain has the general morphological features of the genus Streptomyces. Its whole-cell analysis showed the presence of LL-diaminopimelic acid and of no diagnostic sugars. The colonies had a yellow to deep chrome yellow vegetative myceliumand a turquoise-green aerial myceliumwith sporophores arranged in spirals, coils and hooks. The spores were cylindrical with rounded ends and dimensions of 1.2 x 2~3 jum. Based on the form of the sporophores and on the color of the aerial mycelium, the strain was assigned to the "Group Spira-Green Section". The cultural characteristics of the strain on various standard media, its physiological characteristics and its capacity to utilize different carbon sources are reported in Tables   1,2,and3. Isolation of SB22484 Antibiotics and Chemical Characterization In submerged culture, maximumantibiotic production was obtained after 40 hours of fermentation. The SB22484 antibiotics were present in the supernatant of fermentation broths as a complex of four factors with identical UVspectra which were named1, 2, 3, and 4 according to their elution order in the reverse phase chromatographic system (Fig. 1) . LC-MSanalysis showed that two pairs of isomers were present (1 and 3; 2 and 4) having MW's of 752 and 766, respectively. In the fermentation broths pairs 1 Antibacterial Activity of SB22484 As shown in Table 4 , SB22484 complex is most active against N. caviae and N. gonorrhoeae (MIC 0.5 jug/ml); it is less active against Streptococci and U. urealyticum (MIC 4~8 /ig/ml) and H. influenzae (MIC32 jUg/ml). MICvalues are above 128 /ig/ml for all the other species tested; however, in our experience, someclinical isolates of Enterococci are sensitive to aurodox type antibiotics while others, including the ATCC7080 strain in Table 4 , are resistant (F. Ripamonti and P. B. Goldstein, unpublished data). Against S. pneumoniae L44 the MIC increased from 4jug/ml (without serum) to 16/ig/ml in presence of 50 or 70% serum. There was no significant inoculum effect on the MICfor N. gonorrhoeae L997 determined in broth 104, 106, and 107cfu/ml.
Wewere unable to select SB22484-resistant mutants ofN. gonorrhoeae L997 (frequency <4 x 10" 1 1 at 10/xg/ml).
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Anti-neisseria Activity of SB22484 Table 5 summarizes our MICdata for SB22484 and spectinomycin against 23 N. gonorrhoeae strains, 20 of which are clinical isolates, including several penicillinase producers and one spectinomycin-resistant strain. The median MIC of SB22484 was 2/zg/ml, as compared with 32 for spectinomycin. SB22484 had similar activity against N. meningitidis; the MICrange for 5 strains was l~4^g/ml, as compared with 8~32 for spectinomycin (Table 6 ). SB22484 was bactericidal for N. gonorrhoeae L997 but its action was relatively slow in comparison with spectinomycin (Fig. 3) .
Experimental Infections
Upon subcutaneous administration, SB22484was somewhat effective in S. pyogenes septicemia in the mouse (ED50 174mg/kg). It was not effective in S. pneumoniae septicemia at up to 300mg/kg sc.
Serum Level in the Mouse
Serum levels in the mouse after a single subcutaneous dose of lOOmg/kgare shown in Fig.  4 . The peak level in serum had occurred by the first time point (0.5 hour). Levels declined rapidly with an estimated T1/2 of 0.77 hour. After 6 hours, the concentrations was less than 0.25 jug/ml.
Discussion
Fourteen antibiotics have been described in the literature which are related to aurodox in structure, biosynthesis and mode of action. Newly isolated antibiotics having the antimicrobial spectrum of aurodox type antibiotics were compared with reference standards of this group. Our procedure was based on two parameters: UVabsorption and MW, which usually permitted novelty assessment witnout the need for complete structure determination. The knownaurodox type antibiotics maybe divided into four groups on the basis of their UVabsorption maxima (Table 7) . SB22484 belongs to group I whose general structure is in Fig. 5 . The MW's of the SB22484 antibiotics, determined by LC-MSspectroscopy15), are different from the reference standards of this group. Comparison of the structural characteristics of the SB22484antibiotics with those of other aurodox type compounds of group I showed that SB22484 was unique in lacking one of the two methyl groups at C-32. Moreover, factors 1 and 3 have a methyl group at C-28 instead of the ethyl group of other aurodox type antibiotics. This is noteworthy because these substituents are located in a part of the molecule known to be involved in the inhibition of protein synthesis in cell-free systems16). Since the antibacterial activity of SB22484is comparable to that of other aurodox type antibiotics, these substituents are obviously not essential for inhibition of EF-Tu function. The individual factors of the SB22484 complex have antimicrobial activity comparable to that of the complex (data not shown). SB22484 was evaluated as a potential therapeutic agent for gonococcal infections. It is active against clinical isolates of N. gonorrhoeae including penicillinase-producing strains and a strain resistant to spectinomycin, an antibiotic which can be used in patients allergic to penicillin and for treating penicillin-resistant gonorrhoea. SB22484 is bactericidal against N. gonorrhoeae although more slowly than spectinomycin. SB22484 is also active against U. urealyticum, a microorganism associated with nongonococcal urethritis17), and active against N. meningitidis. The low frequency of resistance to SB22484 in N. gonorrhoeae is probably due to the fact that N. gonorrhoeae, like E. coli, has two genes coding for the EF-Tu protein which is the target of aurodox type antibiotics18). In E. coli, resistance to kirromycin is recessive, necessitating mutations of both the tufA and tufB genes5).
The poor activity of SB22484in experimental septicemias caused by sensitive microorganisms was probably due to its short T1/2. SB22484, like other aurodox type antibiotics, showed low toxicity in the mouse (LD50 > 1,000 mg/kg intraperitoneally).
